Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Neurofibroma, Plexiform 1Metastatic Solid Tumors. 1Melanoma 1Lymphoma 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Acute 1Hematologic Diseases 1Gastrointestinal Stromal Tumors 1Dermoid Cyst 1Burkitt Lymphoma 1Blast Crisis 1

Interventions

AZD 6244 2Imatinib Mesylate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Neurofibroma, Plexiform × Imatinib Mesylate × Clear all
NCT03688568 2021-02-12

Study of Imatinib in Children With Neurofibromatosis and Airway Tumors

Indiana University

Phase 2 Withdrawn
CNS

Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon âš¡